Sofosbuvir/ Velpatasvir/ Voxilaprevir for DAA-experienced HCV Patients:
A Systematic Review and Meta-Analysis
EASL 2023 June 21-24 Vienna
#Pooja DEVAN2, #Kai Le Ashley TIONG2, Jean Ee NEO2, Babu P. MOHAN4, Karn WIJARNPREECHA5, Yew Chong Steve TAM6, Nicola COPPOLA7, Carmen
Monica PREDA8, Yu Jun WONG1,2,3
